As of May 22
| +0.38 / +0.50%|
The 15 analysts offering 12-month price forecasts for LifePoint Health Inc have a median target of 81.00, with a high estimate of 94.00 and a low estimate of 72.00. The median estimate represents a +6.37% increase from the last price of 76.15.
The current consensus among 20 polled investment analysts is to Hold stock in LifePoint Health Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.